+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
EMCURE

Emcure Pharmaceuticals Share Price

 

 

Emcure Pharmaceuticals live price: ₹1810.1. It opened at ₹1,790 vs previous close ₹1,793; intraday high/low: ₹1,840/₹1,786. The 50 & 200 DMA stand at ₹1,748.92/₹1,571.85.

Emcure Pharmaceuticals Performance

  • Today's Low
  • ₹1,786
  • Today's High
  • ₹1,840
  • 52 Week Low
  • ₹1,260
  • 52 Week High
  • ₹1,944
  • Open Price₹1,790
  • Previous Close₹1,793
  • Volume138,088
  • 50 DMA₹1,748.92
  • 100 DMA₹1,671.34
  • 200 DMA₹1,571.85

Emcure Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 4.26%
  • Over 3 Month + 11.02%
  • Over 6 Month + 16.74%
  • Over 1 Year + 39.54%

Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!

Invest Now

Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 37.1
  • PEG Ratio
  • 1
  • Market Cap Cr
  • 34,334
  • P/B Ratio
  • 6.9
  • Average True Range
  • 54.98
  • EPS
  • 49.88
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 29
  • RSI
  • 53.66
  • MFI
  • 56.6

Latest Stock News Updates

Emcure Pharma takes full control of Gennova, names Samit Mehta CEO

Ownership consolidation follows the mRNA business carve-out as Emcure reshapes Gennova's strategy to sharpen its focus on biologics, biosimilars and adjacent therapeutic platforms

Emcure Pharmaceuticals Q4 results: Profit jumps 28%, revenue up by 16%

The rise in profits was attributed to the robust performance in international markets and growth in new launches from Emcure's in-house portfolio

Emcure Pharmaceuticals Results Earnings Call for Q4FY26 & Full Year

Conference Call with Emcure Pharmaceuticals Management and Analysts on Q4FY26 Performance and Outlook. Listen to the full earnings transcript.

Emcure Pharmaceuticals Financials

Emcure Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,810.10
+ 16.8 (0.94%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹1,803.60
  • 50 Day
  • ₹1,748.90
  • 100 Day
  • ₹1,671.30
  • 200 Day
  • ₹1,571.80

Resistance and Support

1812.07 Pivot Speed
  • R3 1,891.93
  • R2 1,865.97
  • R1 1,838.03
  • S1 1,784.13
  • S2 1,758.17
  • S3 1,730.23

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emcure Pharmaceuticals manufactures and markets a wide range of pharmaceutical products, including generics, biosimilars, and injectables. With a global presence in 70+ countries, it focuses on affordable healthcare solutions across therapeutic areas like cardiology, oncology, and women’s health.

Emcure Pharmaceuticals Ltd has an operating revenue of Rs. 9,203.54 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 14% is healthy, ROE of 18% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-05 Audited Results & Final Dividend
2026-02-04 Quarterly Results
2025-11-11 Quarterly Results
2025-08-07 Quarterly Results
2025-05-22 Audited Results & Final Dividend
Date Purpose Remarks
2025-08-14 FINAL Rs.3.00 per share(30%)Final Dividend
View Emcure Pharmaceuticals Dividend History Arrow

Emcure Pharmaceuticals Shareholding Pattern

77.87%
4.94%
0.87%
3.35%
0%
6.46%
6.51%

Emcure Pharmaceuticals FAQs

Emcure Pharmaceuticals share price is ₹1,810 As on 15 July, 2026 | 04:55

The Market Cap of Emcure Pharmaceuticals is ₹34334 Cr As on 15 July, 2026 | 04:55

The P/E ratio of Emcure Pharmaceuticals is 37.1 As on 15 July, 2026 | 04:55

The PB ratio of Emcure Pharmaceuticals is 6.9 As on 15 July, 2026 | 04:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23